4//SEC Filing
Stellar Biotechnologies, Inc. 4
Accession 0001144204-17-016844
$EDSACIK 0001540159operating
Filed
Mar 26, 8:00 PM ET
Accepted
Mar 27, 5:01 PM ET
Size
5.4 KB
Accession
0001144204-17-016844
Insider Transaction Report
Form 4
MORSE DANIEL E.
Director
Transactions
- Award
Share Option (Right to Buy)
2017-03-23+2,500→ 2,500 totalExercise: $1.67Exp: 2024-03-23→ Common Shares (2,500 underlying)
Footnotes (1)
- [F1]Option grant under the 2017 Incentive Compensation Plan, which shall vest as to one-third immediately, as to one-third on March 23, 2018 and as to the remaining one-third on September 23, 2018.
Documents
Issuer
Stellar Biotechnologies, Inc.
CIK 0001540159
Entity typeoperating
IncorporatedBritish Columbia, Canada
Related Parties
1- filerCIK 0001540159
Filing Metadata
- Form type
- 4
- Filed
- Mar 26, 8:00 PM ET
- Accepted
- Mar 27, 5:01 PM ET
- Size
- 5.4 KB